Search

Mutations in a gene related to HER2, a gene frequently implicated in breast cancers and a variety of other malignancies, can amplify activity that spurs tumor growth

More than 500 UT Southwestern Medical Center students, physicians, and health professionals will team up on Saturday, April 27 for the 15th annual Carnaval de Salud, which provides free health care services to underserved populations in Dallas.

Researchers at UT Southwestern Medical Center studied outcomes for young women at a county hospital and found that while 97% of them accessed prenatal care, those with greater social needs were associated with adverse outcomes both during pregnancy and during the early weeks of their babies’ lives

In recognition of outstanding teaching, the UT System’s Kenneth I. Shine, M.D., Academy of Health Science Education is inducting two UT Southwestern educators as new members during its annual conference in Austin.

Jean D. Wilson, M.D., an internationally known endocrinologist whose scientific discoveries led to profound insights into the mechanisms underlying sexual differentiation and led to now widely used treatments for prostate disease, died June 13. He was 88.

UT Southwestern Medical Center’s Center for Depression Research and Clinical Care is collaborating with mental health colleagues across the country to expand detection and treatment for depression and other disorders across Texas as part of the Lone Star Depression Challenge.

UT Southwestern stem cell scientists find that stringent lineage tracing is crucial for studies of nerve cell regeneration.

Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that inevitably develops to cancer drugs that target them, a new study led by UT Southwestern scientists suggests.

A study by UT Southwestern researchers finds that changing the biochemistry of parts of brain cells abolished the formation of amyloid beta plaques in a mouse model of Alzheimer’s disease.

A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.